First Results from the TERAVOLT Registry: mortality among thoracic cancer patients with COVID-19 is unexpectedly high
Mortality rates do not appear to be associated with any specific type of treatment or comorbidity in this patient group
Related Articles
Precision Oncology: Genomics Guided Care – Taxonomy and Framework for Development of Tumour-Agnostic Precision Therapeutics 2024
Precision Oncology: Genomics Guided Care – Taxonomy and Framework for Development of Tumour-Agnostic Precision Therapeutics 2024Chair: Benedikt WestphalenCo-Chair:Â George PentheroudakisSpeakers: Claudia Cardone, Vivek Subbiah, Sewanti Limaye
ESMO Deep Dive: Breast Cancer – Early Stage Triple-negative
This ESMO Webinar Series is available to all ESMO Members.
Real World Data and Digital Oncology – Digital Health as Cancer C
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
ESMO Guidelines: Real World Cases – Webinar Series: Venous
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Susana Banerjee | ESMO Board Member
Susana Banerjee is on the Advisory Board for Nature Reviews Clinical Oncology journal and Editorial Boards of Cancer Treatment Reviews and ESMO Open
MPs to vote on landmark Bill to create Smokefree generation
MPs to vote on legislation to create first smoke-free generation, protecting young people turning 15 this year or younger from harms of smoking
ESMO Daily Reporter
The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society
Precision Oncology: Genomics Guided Care – Taxonomy and Framework
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
EMUC 2024
Plan your participation in EMUC 2024, taking place in Lisbon, Portugal, from 7 to 10 November 2024